Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radka Stoyanova

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Radiogenomic profiling of prostate tumors prior to external beam radiotherapy converges on a transcriptomic signature of TGF-β activity driving tumor recurrenceAnson T Ku, Uma Shankavaram, Shana Y Trostel, et al.
The Canadian Journal of Urology|June 11, 2019
Validation of dominant and secondary sequence utilization in PI-RADS v2 for classifying prostatic lesionsNachiketh Soodana-Prakash, R Patricia Castillo, Isildinha M Reis, et al.
Oncotarget|July 21, 2016
Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsiesRadka Stoyanova, Alan Pollack, Mandeep Takhar, et al.
The Journal of Urology|December 28, 2020
Heterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted BiopsySanoj Punnen, Radka Stoyanova, Deukwoo Kwon, et al.
Cancer Biology & Therapy|January 22, 2005
Altered gene expression in phenotypically normal renal cells from carriers of tumor suppressor gene mutationsRadka Stoyanova, Margie L Clapper, Alfonso Bellacosa, et al.
Urologic Oncology|April 9, 2026
Evaluating MRI findings and biopsy strategies to maximize detection of grade progression in men on active surveillance for prostate cancerSeyed Hossein Hosseini Sharifi, Jonathan T Ryan, Adam Williams, et al.
Prostate Cancer and Prostatic Diseases|September 27, 2024
Evaluating 4Kscore's role in predicting progression on active surveillance for prostate cancer independently of clinical information and PIRADS scoreHelen Y Hougen, Isildinha M Reis, Sunwoo Han, et al.
Academic Radiology|December 18, 2024
HRS Improves Active Surveillance for Prostate Cancer by Timely Identification of ProgressionIsabella M Kimbel, Veronica Wallaengen, Evangelia I Zacharaki, et al.
BJU International|May 6, 2026
Multiparametric MRI in prostate cancer active surveillance: results from the Miami Active Surveillance Trial (MAST) trialSeyed Hossein Hosseini Sharifi, Adam Williams, Jonathan T Ryan, et al.
Cancers|March 14, 2026
mpMRI-Based Risk Estimation to Optimize Prostate Cancer Patient Selection for Active SurveillanceVeronica Wallaengen, Evangelia I Zacharaki, Mohammad Alhusseini, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Radiogenomic profiling of prostate tumors prior to external beam radiotherapy converges on a transcriptomic signature of TGF-β activity driving tumor recurrenceAnson T Ku, Uma Shankavaram, Shana Y Trostel, et al.
The Canadian Journal of Urology|June 11, 2019
Validation of dominant and secondary sequence utilization in PI-RADS v2 for classifying prostatic lesionsNachiketh Soodana-Prakash, R Patricia Castillo, Isildinha M Reis, et al.
Oncotarget|July 21, 2016
Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsiesRadka Stoyanova, Alan Pollack, Mandeep Takhar, et al.
The Journal of Urology|December 28, 2020
Heterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted BiopsySanoj Punnen, Radka Stoyanova, Deukwoo Kwon, et al.
Cancer Biology & Therapy|January 22, 2005
Altered gene expression in phenotypically normal renal cells from carriers of tumor suppressor gene mutationsRadka Stoyanova, Margie L Clapper, Alfonso Bellacosa, et al.
Urologic Oncology|April 9, 2026
Evaluating MRI findings and biopsy strategies to maximize detection of grade progression in men on active surveillance for prostate cancerSeyed Hossein Hosseini Sharifi, Jonathan T Ryan, Adam Williams, et al.
Prostate Cancer and Prostatic Diseases|September 27, 2024
Evaluating 4Kscore's role in predicting progression on active surveillance for prostate cancer independently of clinical information and PIRADS scoreHelen Y Hougen, Isildinha M Reis, Sunwoo Han, et al.
Academic Radiology|December 18, 2024
HRS Improves Active Surveillance for Prostate Cancer by Timely Identification of ProgressionIsabella M Kimbel, Veronica Wallaengen, Evangelia I Zacharaki, et al.
BJU International|May 6, 2026
Multiparametric MRI in prostate cancer active surveillance: results from the Miami Active Surveillance Trial (MAST) trialSeyed Hossein Hosseini Sharifi, Adam Williams, Jonathan T Ryan, et al.
Cancers|March 14, 2026
mpMRI-Based Risk Estimation to Optimize Prostate Cancer Patient Selection for Active SurveillanceVeronica Wallaengen, Evangelia I Zacharaki, Mohammad Alhusseini, et al.
Pageof 11